Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) EBT Margin (2016 - 2025)

Historic EBT Margin for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to 7.14%.

  • Nephros' EBT Margin rose 19400.0% to 7.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.53%, marking a year-over-year increase of 152000.0%. This contributed to the annual value of 0.63% for FY2024, which is 116900.0% up from last year.
  • As of Q3 2025, Nephros' EBT Margin stood at 7.14%, which was up 19400.0% from 5.57% recorded in Q2 2025.
  • In the past 5 years, Nephros' EBT Margin ranged from a high of 11.87% in Q1 2025 and a low of 71.98% during Q1 2022
  • For the 5-year period, Nephros' EBT Margin averaged around 18.16%, with its median value being 11.9% (2023).
  • In the last 5 years, Nephros' EBT Margin crashed by -344000bps in 2022 and then skyrocketed by 640000bps in 2023.
  • Quarter analysis of 5 years shows Nephros' EBT Margin stood at 26.76% in 2021, then dropped by -1bps to 26.94% in 2022, then increased by 29bps to 19.11% in 2023, then soared by 149bps to 9.41% in 2024, then dropped by -24bps to 7.14% in 2025.
  • Its last three reported values are 7.14% in Q3 2025, 5.57% for Q2 2025, and 11.87% during Q1 2025.